- September 22 - 23, 2021
- - ET
- - ET
- Organized By:
- Sponsored By:
2021 Scientific Computing Days Virtual Symposium
Advancing One Health Using Science, Technology and Innovation
September 22-23, 2021 (9:00AM – 4:30PM ET)
FDA Scientific Computing Board
Center for Veterinary Medicine
Errol Strain, PhD
Hesha Duggirala, PhD
|Day 1: September 22, 2021|
Hesha Duggirala, PhD, MPHDay 1 Introduction
|9:05AM – 9:45AM||
Steven Solomon, DVM, MPH Director, Center for Veterinary Medicine, U.S. Food and Drug Administration
One Health: What It Is and Why It’s ImportantDr. Steven Solomon was appointed Director of the Food and Drug Administration’s Center for Veterinary Medicine in January 2017. Dr. Solomon previously served as the Deputy Associate Commissioner for Regulatory Affairs within the Food and Drug Administration’s Office of Regulatory Affairs. He joined FDA in 1990 as a Veterinary Medical Officer in the Center for Veterinary Medicine and has served in various policy and leadership positions in the Office of Regulatory Affairs’ Office of Enforcement, Office of Regional Operations, and as the Assistant Commissioner for Compliance Policy. He also served in the Office of Global Regulatory Operations and Policy. Dr. Solomon earned a Doctor of Veterinary Medicine from Ohio State University and a Master’s in Public Health from Johns Hopkins University.
|9:45AM – 10:30AM||
Sam Westreich, PhD, PMP Senior Project Manager, DNANexus
precisionFDA: Securely Sharing and Analyzing Data in the Cloud
Samuel Westreich has served as the senior project manager for the precisionFDA cloud platform for the last two years, since it was deployed as a production environment. He earned his PhD in genetics and genomics from the University of California, Davis, with a focus on microbiome work. He currently works for DNAnexus, Inc. in Mountain View, California, supporting cloud computing bioinformatics platform development and the creation of pipelines.
|10:30AM – 11:15AM||
Dennis Carroll, PhD Senior Advisor on Global Health Security at URC
Preventing the Next Pandemic: The Power of a Global Viral Surveillance Network
Q&ADr. Dennis Carroll has over 30 years of leadership experience in global health and development. Until recently he served as the Director of the U.S. Agency for International Development’s (USAID) Emerging Threats Division. In this position Dr. Carroll was responsible for providing strategic and operational leadership for the Agency's programs addressing new and emerging disease threats. He currently is a Senior Advisor on Global Health Security at URC and is the Chair of the Leadership Board of the Global Virome Project, an international partnership to build the systems and capacities to detect and characterize future viral threats while they are still circulating in wildlife - enabling the world to better prepare before they spill over into us.
|11:15AM – 12:00PM||
Brian Bird, DVM, PHD, MPH Associate Director, One Health Institute
One Health Challenges and Insights to tackle Emerging Infectious Diseases
Q&ADr. Bird is the Associate Director of the One Health Institute, and Director of the One Health Institute Laboratory of the School of Veterinary Medicine, University of California Davis. He is a veterinarian and a virologist with extensive experience in tackling complex emerging infectious disease challenges using One Health approaches in virus surveillance, outbreak responses, technical capacity building and training, and vaccine countermeasure development.
|12:00PM – 1:00PM||
Poster Session (LIVE via Zoom)
|1:00PM – 2:20PM||Digital Health Innovation Organizer: Donna Mendrick, PhD
The rapid pace of development of artificial Intelligence/ machine learning (AI/ML)-based medical devices brings the promise of advancements for both diagnostics and therapeutics across all medical disciplines. One of the benefits of AI/ML in software resides in its ability to learn from real world use and experience and its capability to improve its performance over time. FDA is actively engaged in advancing the oversight of these technologies through novel regulatory approaches and by fostering responsible and high-quality digital health innovation.
|2:20PM – 2:35PM||Break|
|2:35PM – 4:30PM||Modeling and Simulation Approaches in Regulatory Science Organizer: Tomas Drgon, PhD
Data driven decision making is crucial for effective deployment of FDA regulatory decisions. In this session we will discuss examples of modeling and simulation approaches that were used to aid regulatory decisions. We will also discuss the modeling and simulation expertise needed to perform effective review of FDA regulated products that have a modeling and simulation component (virtual reality in medical devices etc).
|Day 2: September 23, 2021|
|9:00AM – 9:15AM||Errol Strain, PhD Day 2 Introduction, Day 1 Overview|
|9:15AM – 10:00AM||
Bernadette Dunham, DVM, PHD Professorial Lecturer, George Washington University
Q&ABernadette Dunham, DVM, PhD is with the Milken Institute School of Public Health, George Washington Univ. (16-Pres). Dr. Dunham is a member of the National Academies of Sciences, Engineering and Medicine's Board on Agriculture and Natural Resources. Dr. Dunham’s service with the U.S. FDA (02-16) culminated in her position as Director of the Center for Veterinary Medicine (08-16). She was Assistant Director with the American Veterinary Medical Assoc.-Governmental Relations Division (95-02); and Director of Lab Animal Medicine/Adjunct Prof. of Pharmacology, State Univ. N.Y. Health Science Center, Syracuse, NY (87-95).
10:00AM – 10:45AM
Megin Nichols, DVM, MPH, DACVPM Enteric Zoonoses Lead, Centers for Disease Control and Prevention
Spillover: Detecting animal illness outbreaks through human enteric disease surveillance (Part I)Megin Nichols, DVM, MPH, serves as the lead for the team at CDC that investigates multistate outbreaks of Salmonella and E. coli resulting from exposure to animals, pet products and raw milk. Prior to joining CDC, Dr. Nichols worked in her home state at the New Mexico Department of Health for 5 years. She received a Bachelor of Science degree in Animal Science from New Mexico State University, a Doctor of Veterinary Medicine from Colorado State University and a Master of Public Health in Food Safety and Biosecurity from the University of Minnesota. Her areas of interest include: zoonotic disease, food safety, and pediatric health.
Lyndsay Bottichio, DrPH Associate Director for Surveillance (Acting), Centers for Disease Control and Prevention
Spillover: Detecting animal illness outbreaks through human enteric disease surveillance (Part II)
Lyndsay Bottichio, DrPH, is the Acting Associate Director for Surveillance for the Division of Foodborne, Waterborne and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC). Lyndsay has eight years of experience as an enteric disease epidemiologist with expertise in domestic and global outbreak surveillance, response, investigation, and food safety. She also has experience and a focus in development and implementation of novel, cutting-edge technology- driven methodologies, including using technological resources to aid in the detection, management, and response of outbreak investigations. She enjoys teaching and collaborating with partners on the use and future development of technology within the public health sector. Lyndsay earned her Bachelor of Science degree in Zoology and a Master of Public Health degree from The Ohio State University in Columbus, Ohio and a Doctorate in Public Health at the University of Georgia.
|10:45AM – 11:00AM||Break|
|11:00 AM – 12:00 PM||
Cheminformatics in One Health Organizer: Patra Volarath, PhDCheminformatics approaches are one set of tools in the computational toolbox that can be applied to both therapeutic discovery and toxicity prediction. In combination with machine- learning techniques that allow identification of new potential targets or toxicology endpoints, cheminformatics approaches can rapidly address new and emerging One Health issues. This session will first introduce the newly formed FDA Chemical Informatics & Modeling Interest Group and then host three talks that illustrate the role of cheminformatics in One Health.
|12:00PM – 12:30PM||Lunch|
|12:30PM – 2:30PM||
Omics in Action: The Use of Omics Technologies to Support One Health Initiatives Organizer: Alexis Norris, PhDOmics is an essential component to the OneHealth initiative. This session will first introduce the newly formed Omics WG. Subsequent talks will present tools created by FDA scientists to support omics studies, data generated from omics studies, and initiatives underway to standardize and disseminate omics data. The session will conclude with Q&A from the audience.
|2:30PM – 2:45PM||Break|
|2:45PM – 4:15PM||
Data Science is a Team Sport: Supporting Cross-Center Collaboration at FDA via the Data Science and Software Development Working Group Organizer: Kevin Snyder, PhDData science projects at FDA have played a critical role in the modernization of the agency’s approach to its public health mission; however, discerning the appropriate processes and navigating internal infrastructure can be challenging. The Data Science and Software Development (DSSD) Working Group was created by the FDA Health Informatics Advisory Board (HIAB) to help address these challenges.
|4:15PM – 4:30PM||Closing Plenary & Award Ceremony|